Live Breaking News & Updates on Eyepoint pharmaceuticals stock

Stay informed with the latest breaking news from Eyepoint pharmaceuticals stock on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Eyepoint pharmaceuticals stock and stay connected to the pulse of your community

EyePoint Pharmaceuticals (NASDAQ:EYPT) Downgraded by StockNews.com

EyePoint Pharmaceuticals (NASDAQ:EYPT) Downgraded by StockNews.com
modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.

Robertw-baird , Jennison-associates , Institutional-trading-of-eyepoint-pharmaceuticals , Franklin-resources-inc , First-turn-management , Eyepoint-pharmaceuticals-company-profile , Eyepoint-pharmaceuticals-inc , Securities-exchange-commission , Hermes-inc , Eyepoint-pharmaceuticals , Analyst-recommendations-for-eyepoint-pharmaceuticals

EyePoint Pharmaceuticals (NASDAQ:EYPT) Shares Gap Up Following Insider Buying Activity

EyePoint Pharmaceuticals (NASDAQ:EYPT) Shares Gap Up Following Insider Buying Activity
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Darioa-paggiarino , Franklin-resources-inc , First-turn-management , News-ratings-for-eyepoint-pharmaceuticals-daily , Nasdaq , Eyepoint-pharmaceuticals , Securities-exchange-commission , Jpmorgan-chase-co , Eyepoint-pharmaceuticals-inc , Eyepoint-pharmaceuticals-stock , Institutional-investors-weigh-in-on-eyepoint-pharmaceuticals

EyePoint Pharmaceuticals (NASDAQ:EYPT) Stock Price Passes Above Two Hundred Day Moving Average of $17.27

EyePoint Pharmaceuticals (NASDAQ:EYPT) Stock Price Passes Above Two Hundred Day Moving Average of $17.27
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

United-states , American , Darioa-paggiarino , Deutsche-bank , Tower-research-capital , Insider-transactions-at-eyepoint-pharmaceuticals , Nasdaq , Securities-exchange-commission , Jpmorgan-chase-co , American-international-group-inc , Eyepoint-pharmaceuticals-inc

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) SVP Sells $22,500.00 in Stock

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) SVP Sells $22,500.00 in Stock
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Los-angeles , California , United-states , David-scott-jones , Panagora-asset-management-inc , News-ratings-for-eyepoint-pharmaceuticals-daily , Jpmorgan-chase-co , Securities-exchange-commission , Eyepoint-pharmaceuticals-stock , Innovis-asset-management , Nasdaq , Eyepoint-pharmaceuticals-inc

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) SVP David Scott Jones Sells 600 Shares

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report) SVP David Scott Jones sold 600 shares of the business’s stock in a transaction that occurred on Thursday, January 25th. The shares were sold at an average price of $25.00, for a total value of $15,000.00. Following the completion of the sale, the senior vice president now […]

United-states , America , David-scott-jones , Nasdaq , Eyepoint-pharmaceuticals , Eyepoint-pharmaceuticals-stock , Eyepoint-pharmaceuticals-inc , America-corp , Vontobel-holding-ltd , News-ratings-for-eyepoint-pharmaceuticals-daily , Sectoral-asset-management-inc , Quarter-for-eyepoint-pharmaceuticals

EyePoint Pharmaceuticals (NASDAQ:EYPT) Shares Up 5.1%

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report) shares rose 5.1% during mid-day trading on Wednesday . The company traded as high as $21.35 and last traded at $21.01. 560,366 shares were traded during mid-day trading, a decline of 29% from the average daily volume of 791,399 shares. The stock had previously closed at $20.00. […]

Darioa-paggiarino , Schonfeld-strategic-advisors , Nasdaq , Toth-financial-advisory-corp , Barclays-plc , Institutional-investors-weigh-in-on-eyepoint-pharmaceuticals , News-ratings-for-eyepoint-pharmaceuticals-daily , Lazard-asset-management , Eyepoint-pharmaceuticals-inc , Tower-research-capital , Eyepoint-pharmaceuticals